NEXENTIS TECHNOLOGIES INC
NXTSNASDAQ🏆 #3834 by market capUS Equity
$1.87▼ $0.04 (−2.35%)
Live1h—
24h▼ 2.4%
7d▼ 7.4%
14d▲ 18.4%
30d▼ 46.6%
1y▼ 96.8%
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
+18.9%
Healthy
📊Gross Margin
66.2%
High
💵FCF Margin
—
⚖️P/S Ratio
13.1x
Elevated
Otter Score
50
Weak
Trading Snapshot
- Day Range
- $1.85 – $1.88
- 52-Week Range
- $1.43 – $60.48
- Volume
- $6.84B
- Avg Volume
- $8.85B
- Shares Outstanding
- 1.4M
- Next Earnings
- Oct 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $208,521
- Last Q Revenue
- $47,215
- P/E Ratio
- —
- P/S Ratio
- 13.1x
- EPS (TTM)
- $-55.61
- Dividend Yield
- —
Why Investors Own NXTS
- ✓High-growth profile — revenue up +4.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 27% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$208,521▲ +0.1% YoY
Gross Margin (TTM)
26.7%▲ +0.1% YoY
Operating Income (TTM)
$47,334▲ +0.1% YoY
Free Cash Flow (TTM)
$37,951▲ +0.1% YoY
About NEXENTIS TECHNOLOGIES INC
A company profile for NEXENTIS TECHNOLOGIES INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
50/100
Analyst Price Target
ⓘAverage Target
$2.39
▲ +27.9% Upside
High Target$2.94
Low Target$2.18
Based on 32 analysts
Latest News & Updates
ChartMill·14d ago
Which stocks are moving before the opening bell on Tuesday?
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
🛰️
Benzinga·14d ago
Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Select Candidate For A Drug Discovery Campaign
As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport proteins outside its mitochondrial program that appeared compatible with the MITOLINE® enabled structural modelling.
🌌
Benzinga·29d ago
Nexentis Technologies Files Prospectus For Offering 2.573M Common Shares On Behalf Of Selling Shareholders
https://www.sec.gov/Archives/edgar/data/1789192/000149315226033026/forms-1.htm